|
EMF Study
(Database last updated on Mar 27, 2024)
ID Number |
|
2417 |
Study Type |
|
In Vivo |
Model |
|
Free radicals/reactive oxygen species and oxidative damage to DNA were analyzed in Japanese quail embryos exposed in ovo to low intensity 900 MHz fields. |
Details |
|
AUTHORS' ABSTRACT: Burlaka et al. 2013 (IEEE #5758): AIM: Long-term exposure of humans to low intensity radiofrequency electromagnetic radiation (RF-EMR) leads to a statistically significant increase in tumor incidence. Mechanisms of such the effects are unclear, but features of oxidative stress in living cells under RF-EMR exposure were previously reported. Our study aims to assess a production of initial free radical species, which lead to oxidative stress in the cell.
MATERIALS AND METHODS: Embryos of Japanese quails were exposed in ovo to extremely low intensity RF-EMR of GSM 900 MHz (0.25 µW/cm2) during 158-360 h discontinuously (48 c - ON, 12 c - OFF) before and in the initial stages of development. The levels of superoxide (O2·-), nitrogen oxide (NO·), thiobarbituric acid reactive substances (TBARS), 8-oxo-2'-deoxyguanosine (8-oxo-dG) and antioxidant enzymes' activities were assessed in cells/tissues of 38-h, 5- and 10-day RF-EMR exposed and unexposed embryos.
RESULTS: The exposure resulted in a significant persistent overproduction of superoxide and nitrogen oxide in embryo cells during all period of analyses. As a result, significantly increased levels of TBARS and 8-oxo-dG followed by significantly decreased levels of superoxide dismutase and catalase activities were developed in the exposed embryo cells.
CONCLUSION: Exposure of developing quail embryos to extremely low intensity RF-EMR of GSM 900 MHz during at least one hundred and fifty-eight hours leads to a significant overproduction of free radicals/reactive oxygen species and oxidative damage of DNA in embryo cells. These oxidative changes may lead to pathologies up to oncogenic transformation of cells.
|
Findings |
|
Effects |
Status |
|
Completed With Publication |
Principal Investigator |
|
NAS of Ukraine, Kyiv, Ukraine.
|
Funding Agency |
|
?????
|
Country |
|
UKRAINE |
References |
|
Burlaka, A et al. Exp Oncol., (2013) 35:219-225
|
Comments |
|
|
Return
|